Company: INTS
Filing Date: 2025-12-05
Form Type: 8-K
Source: 0001567264-25-000111
Chunk: 0

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-12-05
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As previously reported, on June 6, 2025, Intensity Therapeutics, Inc. (the “ Company”) received a letter (the “ June 2025 Nasdaq Letter”) from The Nasdaq Stock Market (“ Nasdaq”) notifying the Company that for the preceding 30 consecutive business days the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2) (the “ Rule”) for continued listing on Nasdaq (the “ Minimum Bid Price Requirement”). The June 2025 Nasdaq Letter stated that the Company had 180 calendar days, or until December 3, 2025 (the “ Initial Compliance Date”), to demonstrate compliance with the Minimum Bid Price Requirement.

On December 4, 2025, the “ Company received a second letter (the “ December 2025 Nasdaq Letter”) from Nasdaq stating that the Company is eligible for an additional 180 calendar days, or until June 1, 2026, to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A).

The Staff of the Nasdaq (the “ Staff”) determined that the Company is eligible for the second 180 calendar day period, or until June 1, 2026, to regain compliance with the Rule based on the Staff’s determination that the Company must continue to meet the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and the Company’s written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If at any time during this additional time period, the closing bid price of the Company’s common stock on the Nasdaq is at least $1.00 per share for a minimum of ten (10) consecutive business days, the Staff will provide written confirmation of compliance with the Rule and this matter will be closed. The December 2025 Nasdaq Letter from Nasdaq also stated that if the Company chooses to implement a reverse stock split, it must complete the split no later than ten (10) business days prior to the expiration date in order to timely regain compliance.

If compliance with the Rule cannot be demonstrated by June 1,